Related references
Note: Only part of the references are listed.Di-Ras2 promotes renal cell carcinoma formation by activating the mitogen-activated protein kinase pathway in the absence of von Hippel-Lindau protein
Hanyu Rao et al.
ONCOGENE (2020)
Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma
Chen Zhong et al.
BMC CANCER (2019)
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer
Shulin Xiang et al.
JOURNAL OF PINEAL RESEARCH (2019)
RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells
Margie N. Sutton et al.
AUTOPHAGY (2018)
RELN signaling modulates glioblastoma growth and substrate-dependent migration
Markus Schulze et al.
BRAIN PATHOLOGY (2018)
Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146
Shiv Prakash Verma et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2018)
Oncogenic DIRAS3 promotes malignant phenotypes of glioma by activating EGFR-AKT signaling
Yong Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
RNAa and Vector-Mediated Overexpression of DIRAS1 Suppresses Tumor Growth and Migration in Renal Cell Carcinoma
Xin Xu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
Sophie Weil et al.
NEURO-ONCOLOGY (2017)
The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma
Yuqiang Mao et al.
ONCOTARGETS AND THERAPY (2017)
Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
Ruipan Zheng et al.
CLINICAL EPIGENETICS (2017)
MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment
Hua He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases
Carmen Bergom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Di-Ras2 Protein Forms a Complex with SmgGDS Protein in Brain Cytosol in Order to Be in a Low Affinity State for Guanine Nucleotides
Yoshitaka Ogita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts
M. N. Washington et al.
CELL DEATH & DISEASE (2015)
Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma
Jing Chen et al.
MEDICAL ONCOLOGY (2014)
CHK2 kinase in the DNA damage response and beyond
Laura Zannini et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma
Ying-Hui Zhu et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
DNA Hypermethylation and Histone Modifications Downregulate the Candidate Tumor Suppressor Gene RRP22 on 22q12 in Human Gliomas
Natalie Schmidt et al.
BRAIN PATHOLOGY (2012)
Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro
Hai-Ling Tang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Caroline Happold et al.
JOURNAL OF NEUROCHEMISTRY (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel
Chun-Fang Zou et al.
BMC CANCER (2011)
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Dagmar Beier et al.
MOLECULAR CANCER (2011)
DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders
Andreas Reif et al.
NEUROPSYCHOPHARMACOLOGY (2011)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Isolation of neuronal chromatin from brain tissue
Yan Jiang et al.
BMC NEUROSCIENCE (2008)
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss
Markus J. Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Genome-wide approaches to studying chromatin modifications
Dustin E. Schones et al.
NATURE REVIEWS GENETICS (2008)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Di-Ras, a distinct subgroup of Ras family GTPases with unique biochemical properties
K Kontani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Rig is a novel Ras-related protein and potential neural tumor suppressor
CA Ellis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1
R Melchionna et al.
NATURE CELL BIOLOGY (2000)
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
S Matsuoka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
